Severe atopic dermatitis in early infancy: characteristics, challenges and new perspectives in clinical practice

Andreas Benedikt Weins1,2, Sebastian Kerzel3, Christina Schnopp4,5

  • 1Department of Pediatrics, University Hospital Augsburg, Augsburg, Germany.

Insights

Severe atopic dermatitis (AD) in infants requires specialized management due to unique clinical aspects. Early identification and distinguishing AD from inborn errors of immunity are crucial for effective treatment.

Area of Science:

  • Pediatric Dermatology
  • Immunology
  • Genetics

Background:

  • Atopic dermatitis (AD) is highly prevalent in infants and children, with a significant percentage experiencing severe disease.
  • Infants with severe AD present unique psychosocial, neurocognitive, and morphological challenges distinct from adult presentations.
  • Distinguishing severe AD from inborn errors of immunity (IEI) is critical due to overlapping phenotypes.

Purpose of the Study:

  • To provide an age-specific approach for managing severe atopic dermatitis in infants.
  • To guide clinicians in differentiating severe AD from IEI based on clinical and laboratory findings.
  • To offer an update on current management strategies, including systemic treatments for severe infantile AD.

Main Methods:

  • Review of clinical history, dermatological findings, and laboratory markers for distinguishing severe AD from IEI.
  • Analysis of age-specific clinical manifestations in infants with severe AD.
  • Compilation of current evidence for managing severe AD in early infancy.

Main Results:

  • A practical approach is presented for identifying infants with severe AD and differentiating them from IEI.
  • Key clinical and laboratory indicators are highlighted for diagnostic accuracy.
  • Updated recommendations for the general and systemic management of severe infantile AD are provided.

Conclusions:

  • Tailored disease management is essential for infants with severe atopic dermatitis.
  • Early and accurate diagnosis, differentiating AD from IEI, is vital for preventing atopic comorbidity.
  • Current systemic treatment options offer new avenues for managing severe infantile AD effectively.

Related Concept Videos

Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
2.0K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
307
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
272
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
638
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
396